These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 32210549)

  • 1. Plasma Metabolomics and Lipidomics Reveal Perturbed Metabolites in Different Disease Stages of Chronic Obstructive Pulmonary Disease.
    Zhou J; Li Q; Liu C; Pang R; Yin Y
    Int J Chron Obstruct Pulmon Dis; 2020; 15():553-565. PubMed ID: 32210549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-coverage lipidomics analysis reveals biomarkers for diagnosis of acute exacerbation of chronic obstructive pulmonary disease.
    Liu X; Zhang H; Si Y; Du Y; Wu J; Li J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jun; 1201-1202():123278. PubMed ID: 35561641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive plasma metabolomic and lipidomic analyses reveal potential biomarkers for heart failure.
    Zhou J; Chen X; Chen W; Zhong L; Cui M
    Mol Cell Biochem; 2021 Sep; 476(9):3449-3460. PubMed ID: 33974232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of lipid biomarker from serum in patients with chronic obstructive pulmonary disease.
    Liu D; Meister M; Zhang S; Vong CI; Wang S; Fang R; Li L; Wang PG; Massion P; Ji X
    Respir Res; 2020 Sep; 21(1):242. PubMed ID: 32957957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum metabolomics analysis of patients with chronic obstructive pulmonary disease and 'frequent exacerbator' phenotype.
    Ding HZ; Wang H; Wu D; Zhou FC; Zhu J; Tong JB; Gao YT; Li ZG
    Mol Med Rep; 2024 Aug; 30(2):. PubMed ID: 38873983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD.
    Correnti S; Preianò M; Gamboni F; Stephenson D; Pelaia C; Pelaia G; Savino R; D'Alessandro A; Terracciano R
    J Transl Med; 2024 Mar; 22(1):301. PubMed ID: 38521955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic value of homocysteine for the occurrence and acute progression of chronic obstructive pulmonary disease.
    Wei B; Tian T; Liu Y; Li C
    BMC Pulm Med; 2020 Sep; 20(1):237. PubMed ID: 32894108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the metabolomic relationship between lung cancer and chronic obstructive pulmonary disease based on direct infusion mass spectrometry.
    Callejón-Leblic B; Pereira-Vega A; Vázquez-Gandullo E; Sánchez-Ramos JL; Gómez-Ariza JL; García-Barrera T
    Biochimie; 2019 Feb; 157():111-122. PubMed ID: 30439409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progranulin is a novel biomarker for predicting an acute exacerbation of chronic obstructive pulmonary disease.
    Chen X; Liu J; Zhu M; Hu B; Bai F; Jin W; Zhou J; Chen C; Song Y; Pan J
    Clin Respir J; 2018 Oct; 12(10):2525-2533. PubMed ID: 30099848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Untargeted metabolomics of human plasma reveal lipid markers unique to chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
    Nambiar S; Tan DBA; Clynick B; Bong SH; Rawlinson C; Gummer J; Corte TJ; Glaspole I; Moodley YP; Trengove R
    Proteomics Clin Appl; 2021 May; 15(2-3):e2000039. PubMed ID: 33580915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Metabolic Score for Predicting the Acute Exacerbation in Patients with Chronic Obstructive Pulmonary Disease.
    Peng L; You H; Xu MY; Dong ZY; Liu M; Jin WJ; Zhou C
    Int J Chron Obstruct Pulmon Dis; 2023; 18():785-795. PubMed ID: 37180750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma metabolomics and clinical predictors of survival differences in COPD patients.
    Pinto-Plata V; Casanova C; Divo M; Tesfaigzi Y; Calhoun V; Sui J; Polverino F; Priolo C; Petersen H; de Torres JP; Marin JM; Owen CA; Baz R; Cordova E; Celli B
    Respir Res; 2019 Oct; 20(1):219. PubMed ID: 31615518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive metabolomic and proteomic analyses reveal candidate biomarkers and related metabolic networks in atrial fibrillation.
    Zhou J; Sun L; Chen L; Liu S; Zhong L; Cui M
    Metabolomics; 2019 Jun; 15(7):96. PubMed ID: 31227919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation.
    Wu Y; Qin J; He J; Shen Y; Wang H; Li Y; Zeng Q; Dong J; An Y; Xiong S; Feng M; Wen F
    Int J Chron Obstruct Pulmon Dis; 2020; 15():397-407. PubMed ID: 32158205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomic Profiling Differences among Asthma, COPD, and Healthy Subjects: A LC-MS-based Metabolomic Analysis.
    Liang Y; Gai XY; Chang C; Zhang X; Wang J; Li TT
    Biomed Environ Sci; 2019 Sep; 32(9):659-672. PubMed ID: 31635682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptomic analysis and validation reveal the pathogenesis and a novel biomarker of acute exacerbation of chronic obstructive pulmonary disease.
    Wang H; Zhong Y; Li N; Yu M; Zhu L; Wang L; Chen F; Xu Y; Liu J; Huang H
    Respir Res; 2022 Feb; 23(1):27. PubMed ID: 35151329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smokers with COPD Show a Shift in Energy and Nitrogen Metabolism at Rest and During Exercise.
    Holz O; DeLuca DS; Roepcke S; Illig T; Weinberger KM; Schudt C; Hohlfeld JM
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1-13. PubMed ID: 32021139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of histidine and energy homeostasis in chronic obstructive pulmonary disease.
    Diao W; Labaki WW; Han MK; Yeomans L; Sun Y; Smiley Z; Kim JH; McHugh C; Xiang P; Shen N; Sun X; Guo C; Lu M; Standiford TJ; He B; Stringer KA
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2015-2025. PubMed ID: 31564849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation in TCM patterns of chronic obstructive pulmonary disease by comprehensive metabolomic and lipidomic characterization.
    Li J; Liu X; Shi Y; Xie Y; Yang J; Du Y; Zhang A; Wu J
    Front Immunol; 2023; 14():1208480. PubMed ID: 37492573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-Arginine Pathway in COPD Patients with Acute Exacerbation: A New Potential Biomarker.
    Ruzsics I; Nagy L; Keki S; Sarosi V; Illes B; Illes Z; Horvath I; Bogar L; Molnar T
    COPD; 2016; 13(2):139-45. PubMed ID: 26514682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.